Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
10 mg | Warenkorb auf Verfügbarkeit prüfen | € 125,00 |
50 mg | Warenkorb auf Verfügbarkeit prüfen | € 504,00 |
Über diesen Artikel
Produktname
Tideglusib, ≥98% (HPLC)
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: >15 mg/mL
storage temp.
2-8°C
SMILES string
O=C1SN(C(=O)N1Cc2ccccc2)c3cccc4ccccc34
InChI
1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2
InChI key
PMJIHLSCWIDGMD-UHFFFAOYSA-N
Gene Information
human ... GSK3B(2932)
Application
- as a reference compound in ADP-GloTM Kinase assay
- as an allosteric inhibitor of GSK-3β to study its effects on myocardial remodeling and angiogenesis
- as a differentiation agent (specifically a glycogen synthase kinase (GSK)-3β inhibitor) to convert fibroblast cells into octamer-binding transcription factor-4 (OCT4)+ and vascular endothelial growth factor receptor-2 (VEGFR-2/fetal liver kinase-1 (FLK1)+ cells
Biochem/physiol Actions
Features and Benefits
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description ≥98% (HPLC) | description - | description ≥98% (HPLC), from Fusarium sp. | description - |
| assay ≥98% (HPLC) | assay - | assay ≥98% (HPLC) | assay - |
| form powder | form buffered aqueous solution | form powder | form buffered aqueous solution |
| Quality Level 100 | Quality Level 100 | Quality Level 200 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| solubility DMSO: >15 mg/mL | solubility - | solubility DMSO: soluble, acetone: soluble, H2O: insoluble, chloroform: soluble, ethyl acetate: soluble | solubility - |
| color white to beige | color - | color - | color - |
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.



